{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:53:22Z","timestamp":1788252802201,"version":"build-2803163510"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.psychres.2026.117056","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:45:05Z","timestamp":1772095505000},"page":"117056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Acute and long-term psychiatric consequences of synthetic cannabinoids and related novel psychoactive substances: A systematic review"],"prefix":"10.1016","volume":"360","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1717-2530","authenticated-orcid":false,"given":"Valerio","family":"Ricci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Chiappini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Martinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2533-140X","authenticated-orcid":false,"given":"Giuseppe","family":"Maina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.psychres.2026.117056_bib0001","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/15563650.2017.1287373","article-title":"Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity","volume":"55","author":"Abouchedid","year":"2017","journal-title":"Clin. Toxicol."},{"issue":"8","key":"10.1016\/j.psychres.2026.117056_bib0002","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1080\/15563650.2016.1190016","article-title":"Acute intoxication of four individuals following use of the synthetic cannabinoid MAB-CHMINACA","volume":"54","author":"Adamowicz","year":"2016","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.psychres.2026.117056_bib0003","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.2147\/NDT.S107622","article-title":"Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia","volume":"12","author":"Altintas","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.psychres.2026.117056_bib0004","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.forsciint.2017.10.042","article-title":"Three fatalities associated with the synthetic cannabinoids 5F-ADB, 5F-PB-22, and AB-CHMINACA","volume":"281","author":"Angerer","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.psychres.2026.117056_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102199","article-title":"Association between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individuals","volume":"64","author":"Argote","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"3","key":"10.1016\/j.psychres.2026.117056_bib0006","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1476-5381.2009.00582.x","article-title":"JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonist","volume":"160","author":"Atwood","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.psychres.2026.117056_bib0008","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1177\/0269881116658990","article-title":"Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis","volume":"30","author":"Bassir Nia","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.psychres.2026.117056_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2012.11.020","article-title":"Psychoactive \"bath salts\": not so soothing","volume":"698","author":"Baumann","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.psychres.2026.117056_bib0013","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/brainsci8070133","article-title":"Synthetic cannabinoid use in a case series of patients with psychosis presenting to acute psychiatric settings","volume":"8","author":"Bonaccorso","year":"2018","journal-title":"Brain Sci."},{"key":"10.1016\/j.psychres.2026.117056_bib0012","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.drugalcdep.2014.07.009","article-title":"Synthetic cannabinoid use among patients in residential substance use disorder treatment","volume":"143","author":"Bonar","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.psychres.2026.117056_bib0014","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s13181-013-0287-x","article-title":"Recurrent seizures and serotonin syndrome following \u201c2C-I\u201d ingestion","volume":"9","author":"Bosak","year":"2013","journal-title":"J. Med. Toxic.\u202f: Offic. J. Am. Coll. Med. Toxic."},{"issue":"7\u20138","key":"10.1016\/j.psychres.2026.117056_bib0015","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/dta.1686","article-title":"The new drug phenomenon","volume":"6","author":"Brandt","year":"2014","journal-title":"Drug Test. Anal."},{"issue":"7\u20138","key":"10.1016\/j.psychres.2026.117056_bib0017","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/dta.1626","article-title":"The rise of new psychoactive substance use in Australia","volume":"6","author":"Burns","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.psychres.2026.117056_bib0018","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drugalcdep.2014.08.005","article-title":"Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications","volume":"144","author":"Castaneto","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.psychres.2026.117056_bib0020","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11682-018-0023-x","article-title":"Structural connectivity in adolescent synthetic cannabinoid users with and without ADHD","volume":"14","author":"\u00c7elik","year":"2020","journal-title":"Brain ImAging Behav."},{"issue":"3","key":"10.1016\/j.psychres.2026.117056_bib0021","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/15504263.2014.929364","article-title":"Use of synthetic cannabinoids in patients with psychotic disorders: case series","volume":"10","author":"Celofiga","year":"2014","journal-title":"J. Dual Diagn."},{"issue":"4","key":"10.1016\/j.psychres.2026.117056_bib0022","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2675","article-title":"Health risk behaviors with synthetic cannabinoids versus marijuana","volume":"139","author":"Clayton","year":"2017","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.psychres.2026.117056_bib0023","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00213-017-4546-4","article-title":"The effects of synthetic cannabinoids on executive function","volume":"234","author":"Cohen","year":"2017","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.psychres.2026.117056_bib0024","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hup.1242","article-title":"Phenomenon of new drugs on the internet: the case of ketamine derivative methoxetamine","volume":"27","author":"Corazza","year":"2012","journal-title":"Hum. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2026.117056_bib0025","first-page":"89","article-title":"Legal highs\": safe and legal \"heavens\"? A study on the diffusion, knowledge and risk awareness of novel psychoactive drugs among students in the UK","volume":"49","author":"Corazza","year":"2014","journal-title":"Riv. Psichiatr."},{"issue":"5","key":"10.1016\/j.psychres.2026.117056_bib0026","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1080\/15563650.2019.1647344","article-title":"Characteristics and circumstances of synthetic cannabinoid-related death","volume":"58","author":"Darke","year":"2019","journal-title":"Clin. Toxicol."},{"issue":"4","key":"10.1016\/j.psychres.2026.117056_bib0027","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s13181-014-0460-x","article-title":"Presentations to the emergency department following cannabis use\u2014A multi-centre case series from ten European countries","volume":"11","author":"Dines","year":"2015","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.psychres.2026.117056_bib0028","article-title":"Severe psychosis, drug dependence, and hepatitis C related to slamming mephedrone","volume":"2016","author":"Dolengevich-Segal","year":"2016","journal-title":"Case Rep. Psychiatry"},{"key":"10.1016\/j.psychres.2026.117056_bib0029","doi-asserted-by":"crossref","first-page":"21","DOI":"10.12688\/f1000research.3-21.v1","article-title":"A case of severe psychosis induced by novel recreational drugs","volume":"3","author":"Dragogna","year":"2014","journal-title":"F1000Resarch"},{"key":"10.1016\/j.psychres.2026.117056_bib0030","series-title":"European Drug Report 2024: Trends and Developments","year":"2024"},{"issue":"2\u20133","key":"10.1016\/j.psychres.2026.117056_bib0031","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.drugalcdep.2011.01.012","article-title":"Synthetic cannabinoid JWH-018 and psychosis: an explorative study","volume":"117","author":"Every-Palmer","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.psychres.2026.117056_bib0032","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fnbeh.2011.00060","article-title":"Beyond THC: the new generation of cannabinoid designer drugs","volume":"5","author":"Fattore","year":"2011","journal-title":"Front. Behav. Neurosci."},{"issue":"24","key":"10.1016\/j.psychres.2026.117056_bib0033","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1212\/01.wnl.0000437297.05570.a2","article-title":"Ischemic stroke after use of the synthetic marijuana \"spice\"","volume":"81","author":"Freeman","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.psychres.2026.117056_bib0034","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.936209","article-title":"A case of synthetic cannabinoid (K2)-induced posterior reversible encephalopathy syndrome (PRES)","volume":"23","author":"Ghazanfar","year":"2022","journal-title":"Am. J. Case Rep."},{"key":"10.1016\/j.psychres.2026.117056_bib0035","article-title":"Acute effects of the novel psychoactive drug 2C-B on emotions","volume":"2015","author":"Gonz\u00e1lez","year":"2015"},{"key":"10.1016\/j.psychres.2026.117056_bib0038","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.drugalcdep.2014.11.033","article-title":"Monitoring new psychoactive substances (NPS) in The Netherlands","volume":"147","author":"Hondebrink","year":"2015","journal-title":"Drug Alcohol Depend."},{"issue":"10","key":"10.1016\/j.psychres.2026.117056_bib0039","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1176\/appi.ajp.2011.11010176","article-title":"Psychosis associated with synthetic cannabinoid agonists: a case series","volume":"168","author":"Hurst","year":"2011","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2026.117056_bib0040","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jemermed.2013.04.017","article-title":"Bath salts intoxication: a case series","volume":"45","author":"Imam","year":"2013","journal-title":"J. Emerg. Med."},{"issue":"2","key":"10.1016\/j.psychres.2026.117056_bib0041","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00216-015-9116-1","article-title":"Determination of urinary metabolites of XLR-11 by liquid chromatography-quadrupole time-of-flight mass spectrometry","volume":"408","author":"Jang","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"issue":"1","key":"10.1016\/j.psychres.2026.117056_bib0042","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/00952990.2016.1240799","article-title":"Characteristics associated with synthetic cannabinoid use among patients treated in a public psychiatric emergency setting","volume":"43","author":"Joseph","year":"2017","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"5","key":"10.1016\/j.psychres.2026.117056_bib0043","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/00952990.2016.1176177","article-title":"A multicenter retrospective survey of poisoning after consumption of products containing novel psychoactive substances from 2013 to 2014 in Japan","volume":"42","author":"Kamijo","year":"2016","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.psychres.2026.117056_bib0044","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12954-017-0138-1","article-title":"Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological analysis","volume":"14","author":"Kassai","year":"2017","journal-title":"Harm. Reduct. J."},{"issue":"3","key":"10.1016\/j.psychres.2026.117056_bib0045","doi-asserted-by":"crossref","first-page":"290","DOI":"10.5811\/westjem.2016.2.29519","article-title":"Case series of synthetic cannabinoid intoxication from one toxicology center","volume":"17","author":"Katz","year":"2016","journal-title":"Western J. Emerg. Med."},{"issue":"1","key":"10.1016\/j.psychres.2026.117056_bib0046","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/ajad.12318","article-title":"Catatonia secondary to synthetic cannabinoid use in two patients with no previous psychosis","volume":"25","author":"Khan","year":"2016","journal-title":"Am. J. Addctn."},{"key":"10.1016\/j.psychres.2026.117056_bib0047","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.forsciint.2015.12.046","article-title":"Synthetic cannabinoid drug use as a cause or contributory cause of death","volume":"260","author":"Labay","year":"2016","journal-title":"Forensic Sci. Int."},{"issue":"8","key":"10.1016\/j.psychres.2026.117056_bib0048","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1177\/0269881114523866","article-title":"The NBOMe hallucinogenic drug series: patterns of use, characteristics of users and self-reported effects in a large international sample","volume":"28","author":"Lawn","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2026.117056_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.162613","article-title":"Target and suspect screening of (new) psychoactive substances in South Korean wastewater by LC-HRMS","volume":"875","author":"Lee","year":"2023","journal-title":"Sci. Total Environ."},{"issue":"8","key":"10.1016\/j.psychres.2026.117056_bib0050","first-page":"617","article-title":"Identification of synthetic cathinones in blood and urine using liquid chromatography-quadrupole\/time of flight (LC-Q\/TOF) mass spectrometry","volume":"36","author":"Logan","year":"2012","journal-title":"J. Anal. Toxicol."},{"issue":"5","key":"10.1016\/j.psychres.2026.117056_bib0051","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s13054-014-0553-6","article-title":"A 'spicy' encephalopathy: synthetic cannabinoids as cause of encephalopathy and seizure","volume":"18","author":"Louh","year":"2014","journal-title":"Crit. Care"},{"issue":"1\u20133","key":"10.1016\/j.psychres.2026.117056_bib0061","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.schres.2009.12.001","article-title":"The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes","volume":"118","author":"M\u00fcller","year":"2010","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.psychres.2026.117056_bib0052","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1080\/10826084.2016.1263663","article-title":"Clinical characteristics of synthetic cannabinoid use in a large urban psychiatric emergency setting","volume":"52","author":"Manseau","year":"2017","journal-title":"Subst. Use Misuse"},{"issue":"3","key":"10.1016\/j.psychres.2026.117056_bib0053","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jat\/bks136","article-title":"Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology","volume":"37","author":"Marinetti","year":"2013","journal-title":"J. Anal. Toxicol."},{"issue":"13","key":"10.1016\/j.psychres.2026.117056_bib0054","doi-asserted-by":"crossref","first-page":"6944","DOI":"10.3390\/ijerph18136944","article-title":"Club drugs and psychiatric sequelae: an issue of vulnerability and previous psychiatric history","volume":"18","author":"Martinotti","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"5","key":"10.1016\/j.psychres.2026.117056_bib0055","first-page":"567","article-title":"Synthetic cannabinoids: clinical case series of patients with psychotic onset in an Italian inpatient unit","volume":"16","author":"Martinotti","year":"2022","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"issue":"9","key":"10.1016\/j.psychres.2026.117056_bib0056","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1007\/s00213-019-05238-8","article-title":"Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis","volume":"236","author":"Mensen","year":"2019","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.psychres.2026.117056_bib0057","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1056\/NEJMc1313655","article-title":"An outbreak of exposure to a novel synthetic cannabinoid","volume":"370","author":"Monte","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.psychres.2026.117056_bib0058","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s13181-017-0605-9","article-title":"Characteristics and treatment of patients with clinical illness due to synthetic cannabinoid inhalation reported by medical toxicologists: a ToxIC Database study","volume":"13","author":"Monte","year":"2017","journal-title":"J. Med. Toxicol."},{"issue":"10","key":"10.1016\/j.psychres.2026.117056_bib0059","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3390\/ph17101387","article-title":"Club drugs and psychiatric outcomes: a descriptive case series from Spain","volume":"17","author":"Montemitro","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.psychres.2026.117056_bib0062","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13181-014-0451-y","article-title":"Prevalence of rhabdomyolysis in sympathomimetic toxicity: a comparison of stimulants","volume":"11","author":"O'Connor","year":"2015","journal-title":"J. Med. Toxicol."},{"issue":"5","key":"10.1016\/j.psychres.2026.117056_bib0063","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/cap.2012.0004","article-title":"Synthetic cannabinoid-induced psychosis: two adolescent cases","volume":"22","author":"Oluwabusi","year":"2012","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2026.117056_bib0064","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jat\/bkw012","article-title":"Analysis of MT-45, a novel synthetic opioid, in human whole blood by LC-MS-MS and its identification in a drug-related death","volume":"40","author":"Papsun","year":"2016","journal-title":"J. Anal. Toxicol."},{"issue":"10209","key":"10.1016\/j.psychres.2026.117056_bib0065","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0140-6736(19)32231-7","article-title":"New psychoactive substances: challenges for drug surveillance, control, and public health responses","volume":"394","author":"Peacock","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2026.117056_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115053","article-title":"First episode psychosis with and without the use of cannabis and synthetic cannabinoids: psychopathology, global functioning and suicidal ideation and antipsychotic effectiveness","volume":"320","author":"Ricci","year":"2023","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2026.117056_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2025.116496","article-title":"Cannabis use and psychotic-like experiences: a systematic review of biological vulnerability, potency effects, and clinical trajectories","volume":"348","author":"Ricci","year":"2025","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2026.117056_bib0068","doi-asserted-by":"crossref","DOI":"10.1111\/ajad.70048","article-title":"Effects of persistent cannabis use on depression, psychosis, and suicidality following cannabis-induced psychosis: a longitudinal study","author":"Ricci","year":"2025","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.psychres.2026.117056_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106384","article-title":"Novel psychoactive substances and psychosis: a comprehensive systematic review of epidemiology, clinical features, neurobiology, and treatment","volume":"178","author":"Ricci","year":"2025","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"27","key":"10.1016\/j.psychres.2026.117056_bib0070","doi-asserted-by":"crossref","first-page":"692","DOI":"10.15585\/mmwr.mm6527a2","article-title":"Acute poisonings from synthetic cannabinoids","volume":"65","author":"Riederer","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.psychres.2026.117056_bib0071","article-title":"First-episode of synthetic cannabinoid-induced psychosis in a young adult, successfully managed with hospitalization and risperidone","volume":"2016","author":"Roberto","year":"2016","journal-title":"Case Rep. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2026.117056_bib0072","first-page":"123","article-title":"Persistent perceptual disturbances following NBOMe use: a systematic review","volume":"55","author":"Rodriguez","year":"2023","journal-title":"J. Psychoact. Drugs"},{"issue":"10","key":"10.1016\/j.psychres.2026.117056_bib0073","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.ajem.2017.04.044","article-title":"Clinical and financial implications of emergency department visits for synthetic marijuana","volume":"35","author":"Rowley","year":"2017","journal-title":"Am. J. Emerg. Med."},{"issue":"6","key":"10.1016\/j.psychres.2026.117056_bib0074","first-page":"401","article-title":"Emergency presentations following use of synthetic cannabinoids in Edinburgh","volume":"34","author":"Rowley","year":"2017","journal-title":"Emerg. Med. J."},{"issue":"1","key":"10.1016\/j.psychres.2026.117056_bib0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/wps.20174","article-title":"Novel psychoactive substances of interest for psychiatry","volume":"14","author":"Schifano","year":"2015","journal-title":"World Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2026.117056_bib0076","doi-asserted-by":"crossref","first-page":"e989","DOI":"10.4088\/JCP.15m09938","article-title":"Characteristics of synthetic cannabinoid and cannabis users admitted to a psychiatric hospital: a comparative study","volume":"77","author":"Shalit","year":"2016","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2026.117056_bib0078","article-title":"Synthetic cannabinoids: the multi-organ failure and metabolic derangements associated with getting high","volume":"5","author":"Sherpa","year":"2015","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"issue":"2","key":"10.1016\/j.psychres.2026.117056_bib0079","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","article-title":"Pharmacological characterization of designer cathinones in vitro","volume":"168","author":"Simmler","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2026.117056_bib0080","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/hup.2300","article-title":"Novel psychoactive substances as a novel challenge for health professionals: results from an Italian survey","volume":"28","author":"Simonato","year":"2013","journal-title":"Hum. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.psychres.2026.117056_bib0081","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/15563650.2011.590812","article-title":"Clinical experience with and analytical confirmation of \"bath salts\" and \"legal highs\" (synthetic cathinones) in the United States","volume":"49","author":"Spiller","year":"2011","journal-title":"Clin. Toxicol."},{"issue":"2","key":"10.1016\/j.psychres.2026.117056_bib0082","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.psym.2014.11.002","article-title":"Toxicities associated with NBOMe ingestion\u2014A novel class of potent hallucinogens: a case series","volume":"56","author":"Suzuki","year":"2015","journal-title":"Psychosomatics"},{"issue":"5","key":"10.1016\/j.psychres.2026.117056_bib0083","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/15563650.2014.909932","article-title":"Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe","volume":"52","author":"Tang","year":"2014","journal-title":"Clin. Toxicol."},{"issue":"3","key":"10.1016\/j.psychres.2026.117056_bib0084","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/15563650.2013.770870","article-title":"Synthetic cannabinoid use associated with acute kidney injury","volume":"51","author":"Thornton","year":"2013","journal-title":"Clinic. Toxic. (Philadelphia, Pa.)"},{"issue":"10","key":"10.1016\/j.psychres.2026.117056_bib0086","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3109\/15563650.2015.1100306","article-title":"An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA","volume":"53","author":"Tyndall","year":"2015","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.psychres.2026.117056_bib0085","series-title":"AACODS Checklist","author":"Tyndall","year":"2010"},{"key":"10.1016\/j.psychres.2026.117056_bib0087","doi-asserted-by":"crossref","unstructured":"United Nations Office on Drugs and Crime. (2024). World Drug Report 2024. Vienna: UNODC.","DOI":"10.18356\/9789211065534"},{"issue":"1","key":"10.1016\/j.psychres.2026.117056_bib0088","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12888-016-1002-7","article-title":"Psychosis associated with acute recreational drug toxicity: a European case series","volume":"16","author":"Vallersnes","year":"2016","journal-title":"BMC Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.psychres.2026.117056_bib0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.schres.2011.04.022","article-title":"Persistent psychosis following the use of Spice","volume":"130","author":"Van der Veer","year":"2011","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.psychres.2026.117056_bib0091","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3109\/15563650.2016.1171329","article-title":"Epidemiology and clinical features of toxicity following recreational use of synthetic cannabinoid receptor agonists","volume":"54","author":"Waugh","year":"2016","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.psychres.2026.117056_bib0092","first-page":"1","article-title":"Different tokes for different folks: use of cannabis products among a longitudinal cohort of people with heroin dependence","volume":"21","author":"Wilson","year":"2023","journal-title":"Int. J. Ment. Health Addict."},{"issue":"9","key":"10.1016\/j.psychres.2026.117056_bib0093","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3109\/15563650.2010.531021","article-title":"Case series of individuals with analytically confirmed acute mephedrone toxicity","volume":"48","author":"Wood","year":"2010","journal-title":"Clin. Toxicol."},{"issue":"27","key":"10.1016\/j.psychres.2026.117056_bib0095","first-page":"464","article-title":"Withdrawal phenomena and dependence syndrome after the consumption of \"spice gold\"","volume":"106","author":"Zimmermann","year":"2009","journal-title":"Dtsch. \u00c4rztebl. Int."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178126001174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178126001174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:36:07Z","timestamp":1779111367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178126001174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":84,"alternative-id":["S0165178126001174"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2026.117056","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute and long-term psychiatric consequences of synthetic cannabinoids and related novel psychoactive substances: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2026.117056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117056"}}